Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
31
Number of overlapping holdings
24.4%
% of BMED's 140 holdings also in WDNA
35.2%
% of WDNA's 91 holdings also in BMED
Overlap by Weight
Sector Drift (BMED minus WDNA)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in BMED |
Weight in WDNA |
Overlap | |
|---|---|---|---|---|
 |
DANAHER CORP | 2.0% | 1.4% | 1.4% |
|
AMGEN INC | 2.5% | 1.4% | 1.4% |
|
ALNYLAM PHARMACEUTICALS INC | 2.6% | 1.3% | 1.3% |
|
BLUEPRINT MEDICINES CORP. | 1.3% | 2.6% | 1.3% |
|
SAREPTA THERAPEUTICS INC | 1.2% | 1.7% | 1.2% |
Position Highlights (Non-Overlapping Exposures)
BMED Overweight Relative to WDNA
|
BOSTON SCIENTIFIC CORP | 3.7% |
|
AMERISOURCEBERGEN CORP | 3.4% |
|
INTUITIVE SURGICAL INC | 2.8% |
 |
ARGENX SE ADR | 2.4% |
 |
METTLER-TOLEDO INTERNATIONAL | 2.4% |
|
WEST PHARMACEUTICAL SERVICES | 2.3% |
|
MCKESSON CORP | 1.7% |
|
UNITEDHEALTH GROUP INC | 1.6% |
|
WATERS CORP | 1.6% |
|
STRYKER CORP | 1.5% |
BMED Underweight Relative to WDNA
|
TWIST BIOSCIENCE CORP. | -3.9% |
 |
NOVOZYMES A/S-B SHARES | -2.7% |
|
GERON CORP | -2.5% |
|
AGIOS PHARMACEUTICALS INC | -2.4% |
|
FATE THERAPEUTICS INC | -2.2% |
|
VERICEL CORPORATION | -2.1% |
|
ELI LILLY & CO | -2.1% |
|
IOVANCE BIOTHERAPEUTICS INC | -1.7% |
|
NATERA INC | -1.6% |
|
REGENERON PHARMACEUTICALS | -1.4% |